Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, ...

BACKGROUND AND OBJECTIVES: In 1996, the Centers for Disease Control (CDC) issued guidelines for antepartum antibiotic prophylaxis of group B streptococcal (GBS)-positive women. The objective of this ...

August 1, 2011 — The American Academy of Pediatrics (AAP) has issued a policy statement, reported online August 1 in Pediatrics, on preventing perinatal group B streptococcal (GBS) disease. The policy ...

Pregnant women with atopic dermatitis (AD) are more likely to be colonized with group B streptococcus (GBS), compared with other pregnant women, results from a large cross-sectional study suggest.

Washington, DC - June 28, 2016 - Researchers have discovered how the bacteria Group B streptococcus (GBS) avoids detection by the immune system during pregnancy. The findings, reported in the journal ...

WHAT: Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a ...

This is a preview. Log in through your library . Abstract Background. The burden from group B streptococcal (GBS) disease in elderly persons (age, ≥65 years) has increased. Rates of colonization and ...

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS ...

Please provide your email address to receive an email when new articles are posted on . An infant in Oregon was hospitalized with a late-onset group B streptococcus infection that researchers linked ...

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today the U.S. Food and Drug Administration (FDA) clearance of the BD MAX™ Group B Streptococcus (GBS) Assay and Clinical Laboratory ...